palliative assessment tool for parkinson s disease
play

Palliative assessment tool for Parkinsons Disease Ed Richfield - PowerPoint PPT Presentation

Palliative assessment tool for Parkinsons Disease Ed Richfield Consultant Geriatrician North Bristol Trust Respond to need throughout disease trajectory Diagnosi s Symptom s Information Tension Care tension Post Bereavement


  1. Palliative assessment tool for Parkinson’s Disease Ed Richfield Consultant Geriatrician North Bristol Trust

  2. Respond to need throughout disease trajectory Diagnosi s Symptom s Information Tension Care tension Post Bereavement Diagnosis Death Advanced Care Planning, Ethical issues, Management of intractable symptoms

  3. Identifying unmet need Prognosis: Necessary but not sufficient Death Active medical interventions Palliative care McMahon and Thomas - “Palliative phase” of Parkinson’s disease

  4. Prognosis is necessary but not sufficient: The elephant in the room • Dementia – 60% at 12 years ( Butter et al. Neurology 2008; 70: 1017-22) – MCI twice as likely at diagnosis (Aarsland et al. Neurology 2009: 72; 1121-26) • Autonomy • Best interest >> ACP (Richfield et al. [abstract]. Mov Disord 2012; 27 Suppl 1 :551)

  5. Delivering palliative in PD: The problem of numbers Negotiating the Chronic : Palliative interface NAT- Parkinson’s POS-PD ESES-PD

  6. Models of care: symbiosis Chronic palliative interface

  7. 3 Stages of Assessment for unmet palliative care need • 1 – Rapid Identification • Awareness • Tool – Fast / Bedside / Limited patient / clinician burden • 2- Triage • Appropriate response / Sustainable referral • 3- Comprehensive palliative assessment • Less time dependent • Tool – comprehensive symptom assessment • Score for comparison over time

  8. PACA Lee et al. Parkinsonism Relat. Disord 2007; 13: 284–289 • PACA - identify breadth of symptom load • Step 1: Self (patient) generated list of Sx • Step 2: Prompts from Sx check list • Step 3: Grade 1 (present) - 3 (dominating day)

  9. PACA Advantages Disadvantages • Simplicity • Developed in Gen Hospital population • Well established • No PD specific clinimetric testing • Identify and grade Sx • Time consuming?

  10. ESAS PD Miyasaki et al. Parkinsonism Relat Disord 2012: 18; S6-9 • Developed from ESAS with addition of 4 domains: – constipation, – difficulty swallowing, – stiffness – confusion • 14 domains each scored 0-10 • Max score 140

  11. ESAS PD • ESAS PD domains: • Pain Tired • Nauseated Depressed • Anxious Drowsy • Appetite Wellbeing • SOB Other • Constipation Swallowing • Stiffness Confusion

  12. ESAS PD Advantages Disadvantages • PD specific • Content validity? • Quantitative outcome • Clinimetric data for ESAS not ESAS-PD • Demonstrated change in response to interventions • Quick to use

  13. POS-S PD Saleem et al . Palliat Med. 2013;27(8):722-31 • Adaptation of POS-S • 20 domains • GI / Neuro-Psych / Motor / Bladder • Rate 0 (no effect) – 4 (overwhelming) • Max score 80

  14. POS-S PD Advantages Disadvantages • Comprehensive • No change in response to treatment data yet… • Quantitative outcome • Administration burden • Demonstrated change over time • Clinimetric data in PD?

  15. Tackling the chronic / palliative interface. NAT: PD-c • Developed for cancer (Waller et al 2008) • Assess Patient / Carer / Family needs • Clinician administered • Minimal increase in consultation time (Waller et al 2012) • Adapted for other chronic conditions – Heart failure (Waller et al 2013) – ILD (ongoing)

  16. Section 1 Red Flags Section 2 Patient Section 3 wellbein Ability of g carer to care for patient Section 4 Carer / family wellbeing Action s

  17. Triage : NAT: Parkinson’s disease • HCP completed • Normal consultation • No increased clinic time

  18. NAT: Parkinson’s Advantages Disadvantages • Wide ranging • No Quantitative outcome – Patient / carer / family • Less effective for response to • Clinician rated treatment – less patient burden • Clinimetric qualities modest • Rapid • Lack of peer review • Introduces triage of need

  19. Issue specific tools in PD • Myriad available i.e: • Pain • Non-motor • Anxiety • Psycho-social • MDS website https://www.movementdisorders.org/MDS/Education/Rating-Scales.htm

  20. The Model Service? ESAS-PD / POS- PD Symptom specific tools NAT:Parkinson’s disease

  21. NAT: Parkinson’s disease Clinimetric properties Construct Comparator tool Correlation Reliability (Kendal’s tau b) (Weighted kappa) 0.39 Patient Physical PDQ (mobility) 0.51 Patient psych. PDQ (emotion) 0.55 0.33 0.27 Patient ADL MDSUPDRS - 2 0.62 0.21 Patient Spiritual PDQ (emotion) 0.42 Patient financial N/A 0.54 N/A 0.11 Patient health beliefs SCOPA PS 0.26 Carer Distress mCSI 0.63 0.62 Carer Physical MDSUPDRS - 2 0.48 0.48 0.48 Carer difficulty coping mCSI 0.46 Carer Inter-personal mCSI 0.29 0.32 0.28 Carer / family wellbeing mCSI 0.36 Carer / family grief mCSI 0.28 −0.01

  22. Discussion of results • Construct validity – Majority Moderate or Good validity – Difficulty matching broad constructs – PD tools not designed for palliative constructs • Inter-rater reliability – Majority moderate of fair – Low Kappa at high percentage agreement – Range of assessors likely lowered reliability – Learning effect - ?better in real life

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend